Atlas Trials

Richter's Syndrome

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Richter's Syndrome

RecordFirmDate
A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome; (NCT04939363)Bnai Zion Medical Center2021-08-08
Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome (NCT03113695)University of California, San Diego2017-12-20
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies (NCT03263637)AstraZeneca2017-10-24
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies (NCT02362035)Acerta Pharma BV2015-02-20
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia (NCT02029443)Acerta Pharma BV2014-01-30
Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome (NCT01171378)University of Oxford2011-04-01

Track Richter's Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.